Jennifer Brown, MD, PhD, Director, Chronic Lymphocytic Leukemia Center, Dana-Farber Cancer Institute, Assistant Professor of Medicine, Harvard Medical School, discusses the treatment of chronic lymphocytic leukemia with ibrutinib, idelalisib, etc.
Video, Dr. Jennifer Brown.... ibrutinib, idela... - CLL Support
Video, Dr. Jennifer Brown.... ibrutinib, idelalisib, and other agents.
Written by
Cllcanada
Top Poster CURE Hero
To view profiles and participate in discussions please or .
Read more about...
1 Reply
•
Not what you're looking for?
You may also like...
Zanubrutinib vs. Ibrutinib Patient Power Video by Dr. Jennifer Brown MD PHD
Watch as Jennifer Brown, MD, PhD, Director, CLL Center, Dana Farber, updates our chronic...
Dr Sharman's thoughts on the race for FDA Approval for Obinituzumab, Ibrutinib and Idelalisib
to-stop-phase-3-study-116-of-idelalisib-in-chronic-lymphocytic-leukemia-early-because-of-positive-ri
CLL Videos with CLL Expert at the Mayo Clinic... Dr. Tait Shanafelt
Chronic lymphocytic leukemia, or CLL, is a cancer of the blood and bone marrow. In this video, Dr....
Vaccines, Ibrutinib toxicity,Dr. Rai on a cure, Dr Ghia on TP563 testing and ERIC
nmet-need-in-cll-chronic-lymphocytic-leukemia-a-cure/
And Dr. Paolo Ghia discusses harmonization lab
Dr. Mato on what really happens when we must stop our ibrutinib or idelalisib
will be hosting Updates on Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma as part of...
Questions about Richter Syndrome
Imbruvica adverse effects. 
Breaking news form ASH conference: looks like Ibrutinib May be better than FCR for some patients
Zanubrutinib Bests Bendamustine-Rituximab in Previously Untreated CLL/SLL
